Workflow
食品和饮料制造业配料解决方案
icon
Search documents
Ingredion Incorporated 报告第一季度业绩强劲,提高全年展望
Globenewswire· 2025-05-08 07:32
Core Insights - Ingredion Incorporated reported strong performance in Q1 2025, driven by sales growth across global regions, particularly in clean label solutions, with a 34% increase in operating income for the texture and health solutions segment [1][4][10] - The company has raised its full-year earnings expectations due to the excellent performance in the first quarter, emphasizing its commitment to becoming the preferred choice for customers [1][21] - Despite a 4% decline in net sales compared to Q1 2024, the company achieved a 30% increase in reported operating income and a 26% increase in adjusted operating income [4][10][36] Financial Performance - Reported diluted EPS for Q1 2025 was $3.00, down from $3.23 in Q1 2024, while adjusted diluted EPS increased to $2.97 from $2.08 [2][4] - Total net sales for Q1 2025 were $1.813 billion, a decrease of 4% from $1.882 billion in Q1 2024, primarily due to changes in pricing mix and foreign exchange impacts [6][32] - Operating income for Q1 2025 was $276 million, reflecting a 30% increase from $213 million in Q1 2024, with adjusted operating income also showing a significant increase [10][37] Segment Performance - The texture and health solutions segment reported operating income of $99 million, a 34% increase year-over-year, driven by lower raw material costs and increased sales volume [13][37] - The Latin America food and industrial ingredients segment achieved operating income of $127 million, a 26% increase, benefiting from favorable market conditions and cost reductions [15][37] - The U.S./Canada food and industrial ingredients segment saw a slight increase in operating income to $92 million, up 6% year-over-year, attributed to improved product mix and cost management [17][37] Outlook - The company expects full-year 2025 reported EPS to range between $10.93 and $11.63, with adjusted EPS projected between $10.90 and $11.60, reflecting anticipated sales growth despite potential pricing and foreign exchange challenges [21][23] - For 2025, net sales are expected to achieve low single-digit growth, with operating income projected to grow close to 20% due to last year's impairment charge base effect [21][22] - The company anticipates a moderate increase in costs for the year, with capital expenditures expected to be between $400 million and $450 million [22][23]